FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...

(3:1econd)

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma

(5:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of ABECMA (idecabtagene vicleucel) the first FDA appro...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutro...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Trodelvy (sacituzumab govitecan-hziy) for HR-positi...

(4:1econd)

FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia

(6:31)

Apex Triggers - 71 (Deloitte Interview Scenario)

(14:14)

Navigating FDA's Drug Information Resources

(50:52)

Congressional Hearing with the FDA

(9:52)

Dollar - Oh L'Amour - TOTP 1988

(2:42)

FDA D.I.S.C.O. Burst Edition: FDA approval of Retevmo (selpercatinib) for advanced or metastatic ...

(4:1econd)

2025.1.15 Midday Mate

(1:54:31)

IFA Wartburg - The free German youth / IFA Wartburg - Freie Deutsche Jugend (FDJ)

(4:37)

FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory ped...

(4:1econd)

January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting

(7:49:20)

FDA D.I.S.C.O.: FDA approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma

(6:31)

FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur

(3:21)

New FDA rule limits nicotine in cigarettes

(25)

FDA D.I.S.C.O. Burst Edition: FDA approval of Imfinzi (durvalumab) for adult patients with locall...

(3:31)

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

(6:1econd)

FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

(6:1econd)

FDA D.I.S.C.O.: A new drug approval for non-metastatic castration-resistant prostate cancer

(5:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approvals of Rituxan (rituximab) plus chemotherapy for pediatri...

(7:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Lynparza (olaparib), with abiraterone and prednison...

(3:31)

FDA D.I.S.C.O.: FDA approval of larotrectinib for advanced malignancies with NTRK gene fusion

(7:31)

FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

(8:1econd)

FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer

(8:31)

FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia

(5:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with met...

(3:31)